drugset / Trial / NCT07583511
Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the efficacy and safety between teniposide, cisplatin and serplulimab regimen and etoposide, cisplatin and serplulimab regimen in the treatment of extensive stage small lung cancer
Timeline
- Start
- 2024-02-01
- Primary completion
- 2027-05-01
- Completion
- 2027-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Etoposide | Small molecule | — | — |
| Subject | Teniposide | Small molecule | — | — |
| Background | Cisplatin | Other / unclassified | — | — |
| Background | Serplulimab | Monoclonal antibody | — | — |